Financial Year |
March 31 2023 |
Monetary Funds |
143,953,813.25 |
Held-for-trading Financial Assets |
200,717,650.35 |
Notes Receivable |
42,551,815.92 |
Accounts Receivable |
238,709,792.19 |
Advances to Suppliers |
3,904,640.66 |
Other Receivables |
16,822,602.22 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
240,313,858.24 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
285,255.83 |
Total Current Assets |
933,341,824.23 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
799,235,017.58 |
Investment Properties |
3,810,245.71 |
Fixed Assetes |
417,227,419.67 |
Under-construction Projects |
6,209,078.23 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
7,686,026.86 |
Oil and Gas Assets |
-- |
Intangible Assets |
32,226,427.59 |
R&D expenses |
-- |
Goodwill |
14,789,430.33 |
Long-Term Deferred and Prepaid Expenses |
15,609,687.77 |
Deferred Income Tax Assets |
1,976,356.31 |
Other Non-Current Assets |
136,511,751.97 |
Sub-Total of Non-Current Assets |
1,435,281,442.02 |
Total Assets |
2,368,623,266.25 |
Short-Term Loans |
120,150,197.61 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
34,252,555.86 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
23,328,645.44 |
Taxes Payable |
18,556,261.81 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
173,388,152.64 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
23,559,297.80 |
Sub-Total of Current Liabilities |
394,985,116.66 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,356,199.13 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
18,847,546.42 |
Total Liabilities |
413,832,663.08 |
Paid-In Capital(Or Share Stock) |
503,200,000.00 |
Capital Surplus |
234,116,276.27 |
Surplus Reserve |
157,692,390.54 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,058,690,134.44 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,954,790,603.17 |
Owner's Equity(Stockholder's Equity) |
1,954,790,603.17 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,368,623,266.25 |